Applications, challenges and future directions of artificial intelligence in cardio-oncology.

Journal: European journal of clinical investigation

PMID: 40191923

Abstract

BACKGROUND: The management of cardiotoxicity related to cancer therapies has emerged as a significant clinical challenge, prompting the rapid growth of cardio-oncology. As cancer treatments become more complex, there is an increasing need to enhance diagnostic and therapeutic strategies for managing their cardiovascular side effects.

Authors

Francesco Ravera

Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy.
Nicolò Gilardi

Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy.
Alberto Ballestrero

Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy.
Gabriele Zoppoli

Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy.

Keywords

Antineoplastic Agents Artificial Intelligence Biomarkers Cardio-Oncology Cardiology Cardiotoxicity Cardiovascular Diseases Electrocardiography Electronic Health Records Humans Medical Oncology Neoplasms Risk Assessment Wearable Electronic Devices

External Resources

View on PubMed Access via DOI PubMed (40191923)

Applications, challenges and future directions of artificial intelligence in cardio-oncology.

Abstract

Authors

Keywords

External Resources

Popular Topics

Recent Journals